AstraZeneca announces $50B investment in U.S., including Virginia facility

President Trump said Tuesday that pharmaceutical giant AstraZeneca will invest $50 billion in pharmaceutical manufacturing by 2030, a development he attributed to his threat to impose tariffs on drugs made outside the U.S.